about
Acute kidney injury: risk factors and management challenges in developing countriesNutritional parameters are associated with mortality in acute kidney injury.Effect of peritoneal dialysis on respiratory mechanics in acute kidney injury patients.Dialysis complications in AKI patients treated with extended daily dialysis: is the duration of therapy important?Extended daily dialysis in acute kidney injury patients: metabolic and fluid control and risk factors for death.Peritoneal Dialysis in Acute Kidney Injury: Trends in the Outcome across Time Periods.Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGALApproach to the Metabolic Implications of Peritoneal Dialysis in Acute Kidney Injury.Long-term outcome of patients followed by nephrologists after an acute tubular necrosis episodeHypothyroidism and acute kidney injury: an unusual association.Erythrocyte superoxide dismutase as a biomarker of septic acute kidney injury.Metabolic implications of peritoneal dialysis in patients with acute kidney injury.Approach to prophylactic measures for central venous catheter-related infections in hemodialysis: a critical review.Peritoneal dialysis for acute kidney injury.Acute PD: Evidence, Guidelines, and Controversies☆.Acute kidney injury after massive attack of Africanised bees.The long-term outcome after acute kidney injury: a narrative review.Approach to thrombotic occlusion related to long-term catheters of hemodialysis patients: a narrative review.Acute kidney injury in elderly intensive care patients from a developing country: clinical features and outcomeA combination of corticosteroid, sirolimus, and intradialytic parenteral nutrition in encapsulating peritoneal sclerosis: Case report and literature review.Estimating Catabolism: A Possible Tool for Nutritional Monitoring of Patients With Acute Kidney Injury.Resting energy expenditure in critically ill patients: Evaluation methods and clinical applications.Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients.Peritoneal Dialysis Treatment Modality Option in Acute Kidney Injury.Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.Peritoneal dialysis can be an option for unplanned chronic dialysis: initial results from a developing country.Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.Dialysis complications in acute kidney injury patients treated with prolonged intermittent renal replacement therapy sessions lasting 10 versus 6 hours: results of a randomized clinical trial.Long-term outcome of severe acute kidney injury survivors followed by nephrologists in a developing country.Acute kidney injury in septic patients admitted to emergency clinical room: risk factors and outcome.Different outcomes of peritoneal catheter percutaneous placement by nephrologists using a trocar versus the Seldinger technique: the experience of two Brazilian centers.Epidemiology of healthcare-associated infections among patients from a hemodialysis unit in southeastern Brazil.Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.Total body water and failure to control blood pressure by medication in hemodialysis patients.Renal Support for Acute Kidney Injury in the Developing World.Handgrip strength and weight predict long-term mortality in acute kidney injury patients.Protein carbonyl concentration as a biomarker for development and mortality in sepsis-induced acute kidney injury.Peritoneal dialysis as the first dialysis treatment option initially unplanned.Peritoneal Dialysis for the Treatment of Cardiorenal Syndrome Type 1: A Prospective Brazilian Study.What Is the Adequate Dose for Peritoneal Dialysis in Acute Kidney Injury: Lower the Bar or Shift the Goalposts?
P50
Q26859090-7E4CF81D-74B5-4625-A8DF-5A42B342473DQ33846354-D74821B9-2A2A-4AA5-8C03-7166822BA644Q33967857-CB84D851-8C20-4CAF-B837-B542892F795EQ34081611-DE061231-4D79-4F36-B334-A5CAF4A4EDB6Q35069729-5A18DD9B-959E-4BAF-BE60-5A82A3FA52E1Q35597230-DDE9A2D0-281C-43DA-98CD-A33A9F06587DQ35894445-CCF925BE-2364-48F5-A5C8-16C787905E41Q35904406-33AE8BAF-0EEC-4345-B2A0-184A7AB8723FQ36446751-6B57746A-D055-499E-8D1A-0685EDAA9ABEQ37145811-4ECAEB52-914F-42C3-B8A0-A599B0620E5EQ37314012-5E5AC84C-5923-4017-BF7D-24477D9E1DD2Q37389803-048C7459-5ABE-42B4-ADC0-638A9E135052Q38128919-26B9BF74-7566-471E-A0D0-8C63E1AE11E7Q38235238-210D189F-1B19-472B-8BCA-7721EE9329B3Q38373670-E6F33973-7FB3-40C4-8BAF-D87F73A6F391Q38412994-8997C5E8-898B-48C2-87F3-305EE620A7A1Q38449102-637105F5-9680-44F6-ACEB-EA18B3F0B557Q38543957-70D16B9C-A00A-4587-BB8B-D4D96748994DQ38956336-3DEC5729-F6B3-47F0-9DFE-9749A3F6FE8EQ38977025-D8390033-1FA9-47AE-ADF8-7BC5B6FC1DEEQ38997702-68FCE2A6-836E-4CFE-B320-CCBF3CAC1DDDQ39031230-572BDB21-EE6D-445E-82F6-A025A193587BQ39092958-1CCC56A4-4722-4DD5-957D-60283BBA00F1Q39099077-9DA185AD-B80F-4F34-89F9-D16432C57394Q40802065-CDEE3ABF-9E3E-41EF-82A1-CD09C2338309Q40898281-7818F778-8ACB-4E48-A8C4-FF31FC4B3A00Q41306852-D5D39E8E-1853-4476-91D2-CB5E4F928817Q41342437-AE32E3F8-CD41-48DE-9253-61ADE6D9A11FQ41361990-33CB08E0-3FCB-411A-AEF3-B0F1A9079F5FQ41580212-A9926030-86E0-4038-A5B7-F461E3DE97F5Q42214174-329D6B5D-DB47-41F1-BC9C-0382190886A4Q42239268-7AF82BC5-7847-4C01-B6A6-2F5AA516DAA2Q42244691-01C1C92C-0EB9-4B2B-82C6-042A95BA1E8EQ42787220-24929378-2FA9-4BC6-AFD4-E285E5CD60E4Q46100875-A5844220-ACE8-4091-B11C-945D02FFD3F1Q47224567-1148C797-C78E-43C6-85D7-0BDE647C0673Q47269410-76DD525B-A031-419B-B4C6-0B056FFD1749Q47562225-50B015A1-1EC3-4586-9CBA-39E691D06F78Q49983013-83810C15-9D88-4460-B151-85178352C77BQ49984197-32ADF578-E41E-49AE-A3FF-4DD7D2C7DA53
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniela Ponce
@ast
Daniela Ponce
@en
Daniela Ponce
@es
Daniela Ponce
@nl
Daniela Ponce
@sl
type
label
Daniela Ponce
@ast
Daniela Ponce
@en
Daniela Ponce
@es
Daniela Ponce
@nl
Daniela Ponce
@sl
prefLabel
Daniela Ponce
@ast
Daniela Ponce
@en
Daniela Ponce
@es
Daniela Ponce
@nl
Daniela Ponce
@sl
P106
P21
P31
P496
0000-0002-6178-6938